ALK and lung adenocarcinoma: In addition, multiple gene fusions, such as NRG1, RET, and ALK, were only detected in IMA patients in our cohort and the detecting rate (16/51, 31.4%) of gene fusions was significantly higher than the unselected lung adenocarcinoma patients (34).